Disease, Disability, and Injury Prevention and Control; Special Emphasis Panel (SEP): Associations of Vaccine Adverse Events and Human Genetic Variations, Request for Proposal Number (RFP) 2008-R-VAC01, 30105 [E8-11589]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 101 / Friday, May 23, 2008 / Notices
HHS to contact you if further
information on the substance of the
comment is needed or if your comment
cannot be read due to technical
difficulties. HHS’s policy is that HHS
will not edit your comment, and any
identifying or contact information
provided in the body of a comment will
be included as part of the comment
placed in the official public record. If
HHS cannot read your comment because
of technical difficulties and cannot
contact you for clarification, HHS may
not be able to consider your comment.
Written comments to be available at the
meeting will be accepted up to Friday,
May 30, 2008.
Documents pertaining to Committee
deliberations will be available upon
written request beginning on June 9,
2008. Requests should be sent to
AdvisoryCommittee@pal-tech.com with
‘‘Materials Request’’ in the subject line
and should include include your name,
mailing address, and an e-mail address
or other contact information.
Because of the Advisory Committee’s
full agenda and the timeframe in which
to cover the agenda topics, there will be
no opportunity for oral presentations
from the public at this meeting. The
public will be able to submit comments
to AdvisoryCommittee@pal-tech.com
both before and after the meeting; these
will be included in the public record.
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of proposals received in response
to ‘‘Associations of Vaccine Adverse Events
and Human Genetic Variations, Request for
Proposal (RFP) Number 2008–R–VAC01.’’
Contact Person for More Information:
Christine J. Morrison, PhD, Scientific Review
Administrator, CDC, 1600 Clifton Road, NE.,
Mailstop D72, Atlanta, GA 30333, Telephone:
(404) 639–3098.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: May 15, 2008.
Daniel Schneider,
Acting Assistant Secretary for Children and
Families.
[FR Doc. E8–11552 Filed 5–22–08; 8:45 am]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
dwashington3 on PRODPC61 with NOTICES
Disease, Disability, and Injury
Prevention and Control; Special
Emphasis Panel (SEP): Associations of
Vaccine Adverse Events and Human
Genetic Variations, Request for
Proposal Number (RFP) 2008–R–
VAC01
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 12 p.m.–2 p.m., June 12,
2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
VerDate Aug<31>2005
15:34 May 22, 2008
Jkt 214001
Dated: May 16, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–11589 Filed 5–22–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–R–138, CMS–
10147, CMS–10146 and CMS–10064]
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Medicare
Geographic Classification Review Board
AGENCY:
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
30105
(MGCRB) Procedures and Criteria and
Supporting Regulations in 42 CFR
412.256 & 412.230; Use: Section
1886(d)(10) of the Social Security Act
established the MGCRB, an entity that
has the authority to accept short-term
hospital inpatient prospective payment
system (IPPS) hospital applications
requesting geographic reclassification
for wage index or standardized payment
amounts and to issue decisions on these
requests. Since it is important to ensure
the accuracy of the MGCRB decisions
and remain apprised of potential
payment impacts, the regulations note
that CMS should also receive a copy of
any hospital’s application to the
MGCRB. The information submitted by
the hospitals is used by CMS staff to
determine the validity of the hospitals’
requests and the discretion used by the
MGCRB in reviewing and making
decisions regarding hospitals’ requests
for geographic reclassification. Since
CMS wrote the guidelines for the
MGCRB, it is essential that CMS staff
monitor this process. Form Number:
CMS–R–138 (OMB# 0938–0573);
Frequency: Yearly; Affected Public:
Business or other for-profits and not-forprofit institutions; Number of
Respondents: 300; Total Annual
Responses: 300; Total Annual Hours:
300.
2. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Medicare
Prescription Drug Coverage and Your
Rights; Use: Section 42 CFR 423.562,
requires each Part D plan sponsor to
arrange with its network pharmacies to
post or distribute the Medicare
Prescription Drug Coverage and Your
Rights notice to Part D plan enrollees at
each pharmacy visit when the enrollee
disagrees with the information provided
by the pharmacist. The purpose of this
notice is to provide enrollees with
information about how to contact their
Part D plans to request a coverage
determination, including a request for
an exception to the Part D plan’s
formulary. Form Number: CMS 10147
(OMB# 0938–0975); Frequency: Daily;
Affected Public: Business or other forprofits; Number of Respondents: 40,000;
Total Annual Responses: 30,000,000;
Total Annual Hours: 500,000.
3. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Notice of Denial
of Medicare Prescription Drug Coverage;
Use: Section 1860D–4(g)(1) of the Social
Security Act, requires Part D plan
sponsors that deny prescription drug
coverage to provide a written notice of
the denial to the enrollee. The written
E:\FR\FM\23MYN1.SGM
23MYN1
]]>Agencies
[Federal Register Volume 73, Number 101 (Friday, May 23, 2008)]
[Notices]
[Page 30105]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-11589]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control; Special
Emphasis Panel (SEP): Associations of Vaccine Adverse Events and Human
Genetic Variations, Request for Proposal Number (RFP) 2008-R-VAC01
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 12 p.m.-2 p.m., June 12, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review,
discussion, and evaluation of proposals received in response to
``Associations of Vaccine Adverse Events and Human Genetic
Variations, Request for Proposal (RFP) Number 2008-R-VAC01.''
Contact Person for More Information: Christine J. Morrison, PhD,
Scientific Review Administrator, CDC, 1600 Clifton Road, NE.,
Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639-3098.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: May 16, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-11589 Filed 5-22-08; 8:45 am]
BILLING CODE 4163-18-P
